Diebold Nixdorf (DBD) Securities Investigation Notice - Levi & Korsinsky

Diebold Nixdorf shares fell after the Company cut its full-year 2026 earnings and cash-flow outlook, citing a heavier retail/point-of-sale shipment mix and rising memory and component costs. Levi & Korsinsky is investigating potential securities law violations on behalf of investors who lost money.

NEW YORK, Nov. 4, 2026 /PRNewswire/ -- Diebold Nixdorf (NYSE: DBD) shares opened down more than 9% the morning following the Company's October 28, 2026 third-quarter report. The report lowered the Company's full-year 2026 adjusted EPS outlook from $5.25-$5.75 to $4.50-$4.85, citing higher memory and component costs and a lower-margin product mix. If you own DBD and lost money on this news, you may have legal rights. Investors who suffered losses are encouraged to submit their DBD loss information now. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

The Company tied the revision to "a change in revenue mix and cost pressures in raw materials." Management named two specific pressures:

• Increased retail/point-of-sale shipments, which carry lower margins
• Higher memory and component costs

Adjusted EBITDA guidance moved from $510 million-$535 million to $490 million-$510 million.

The cash-flow reduction was steeper. Free cash flow guidance dropped from $255 million-$270 million to $190 million-$210 million. That is $62.5 million, or about 24%, lower at the midpoint. At the midpoint, adjusted EPS guidance fell by about $0.83 per share, or roughly 15%. Levi & Korsinsky has opened an investigation on behalf of DBD shareholders concerning potential securities law violations.

Shareholders who lost money on Diebold Nixdorf stock may request a free review of their losses or call (212) 363-7500.

ABOUT LEVI & KORSINSKY, LLP -- Over the past 20 years, Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders. The firm has extensive expertise in complex securities litigation and a team of over 70 employees. For seven consecutive years, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report.

Frequently Asked Questions About the DBD Investigation

Q: Who is conducting the DBD investigation? A: Levi & Korsinsky, LLP is investigating potential securities law violations on behalf of investors who purchased DBD securities. The firm is nationally recognized and has been ranked in the ISS Top 50 for seven consecutive years. It has recovered hundreds of millions of dollars for aggrieved investors.

Q: Who is eligible to participate in the DBD investigation? A: Investors who purchased DBD stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.

Q: What do DBD investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible to participate in the investigation.

Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my DBD shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought DBD and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. If you choose to participate in any resulting action, these matters are generally handled on a contingency basis. Any attorneys' fees and expenses are subject to court approval.

Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

SOURCE Levi & Korsinsky, LLP